Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors

ACS Nano

Volumn 7, Issue 1, 2013, Pages 717-724

  Sano, Kohei ^a   Nakajima, Takahito ^a   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cancer imaging; cancer therapy; drug delivery; nanomaterials; photoimmunotherapy; super enhanced permeability and retention effect

Indexed keywords

CANCER CELLS; CANCER IMAGING; CANCER THERAPY; DAUNORUBICIN; ENHANCED PERMEABILITY AND RETENTION EFFECT; PHOTOIMMUNOTHERAPY; SUPER-ENHANCED PERMEABILITY AND RETENTION EFFECT; TUMOR BED; VASCULAR PERMEABILITY;

DRUG DELIVERY; MEDICAL IMAGING; NANOSTRUCTURED MATERIALS; PHOTOSENSITIZERS;

TUMORS;

ANTINEOPLASTIC ANTIBIOTIC; DAUNORUBICIN; NANOCAPSULE; PHOTOSENSITIZING AGENT;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNOTHERAPY; LIGHT; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; PERMEABILITY; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DAUNORUBICIN; FEMALE; IMMUNOTHERAPY; LIGHT; MICE; MICE, NUDE; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; PERMEABILITY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84872838282     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn305011p     Document Type: Article

References (26)

1. Minchinton, A. I.; Tannock, I. F. Drug Penetration in Solid Tumours Nat. Rev. Cancer 2006, 6, 583-592
2. Hambley, T. W.; Hait, W. N. Is Anticancer Drug Development Heading in the Right Direction? Cancer Res. 2009, 69, 1259-1262
3. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760
4. Maeda, H. Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects Bioconjugate Chem. 2010, 21, 797-802
5. Maeda, H.; Matsumura, Y. EPR Effect Based Drug Design and Clinical Outlook for Enhanced Cancer Chemotherapy Adv. Drug Delivery Rev. 2011, 63, 129-130
6. Vicent, M. J.; Duncan, R. Polymer Conjugates: Nanosized Medicines for Treating Cancer Trends Biotechnol. 2006, 24, 39-47
7. Jain, R. K. The Next Frontier of Molecular Medicine: Delivery of Therapeutics Nat. Med. 1998, 4, 655-657
8. Vaage, J.; Donovan, D.; Mayhew, E.; Abra, R.; Huang, A. Therapy of Human Ovarian Carcinoma Xenografts Using Doxorubicin Encapsulated in Sterically Stabilized Liposomes Cancer 1993, 72, 3671-3675
9. Forssen, E. A.; Coulter, D. M.; Proffitt, R. T. Selective in Vivo Localization of Daunorubicin Small Unilamellar Vesicles in Solid Tumors Cancer Res. 1992, 52, 3255-3261
10. Presant, C. A.; Scolaro, M.; Kennedy, P.; Blayney, D. W.; Flanagan, B.; Lisak, J.; Presant, J. Liposomal Daunorubicin Treatment of HIV-Associated Kaposi's Sarcoma Lancet 1993, 341, 1242-1243
11. Mitsunaga, M.; Ogawa, M.; Kosaka, N.; Rosenblum, L. T.; Choyke, P. L.; Kobayashi, H. Cancer Cell-Selective in Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules Nat. Med. 2011, 17, 1685-1691
12. Giusti, R. M.; Shastri, K.; Pilaro, A. M.; Fuchs, C.; Cordoba-Rodriguez, R.; Koti, K.; Rothmann, M.; Men, A. Y.; Zhao, H.; Hughes, M. et al. U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor-Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Containing Chemotherapy Regimens Clin. Cancer Res. 2008, 14, 1296-1302
13. Waldmann, T. A. Immunotherapy: Past, Present, and Future Nat. Med. 2003, 9, 269-277
14. Reichert, J. M.; Rosensweig, C. J.; Faden, L. B.; Dewitz, M. C. Monoclonal Antibody Successes in the Clinic Nat. Biotechnol. 2005, 23, 1073-1078
15. Weinstein, J. N.; Eger, R. R.; Covell, D. G.; Black, C. D.; Mulshine, J.; Carrasquillo, J. A.; Larson, S. M.; Keenan, A. M. The Pharmacology of Monoclonal Antibodies Ann. N.Y. Acad. Sci. 1987, 507, 199-210
16. Weinstein, J. N.; van Osdol, W. Early Intervention in Cancer Using Monoclonal Antibodies and Other Biological Ligands: Micropharmacology and the "Binding Site Barrier" Cancer Res. 1992, 52, 2747s-2751s
17. Weissleder, R.; Stark, D. D.; Engelstad, B. L.; Bacon, B. R.; Compton, C. C.; White, D. L.; Jacobs, P.; Lewis, J. Superparamagnetic Iron Oxide: Pharmacokinetics and Toxicity AJR Am. J. Roentgenol. 1989, 152, 167-173
18. Kobayashi, H.; Brechbiel, M. W. Nanosized MRI Contrast Agents with Dendrimer Cores Adv. Drug Delivery Rev. 2005, 57, 2271-2286
19. Clarke, S. E.; Weinmann, H. J.; Dai, E.; Lucas, A. R.; Rutt, B. K. Comparison of Two Blood Pool Contrast Agents for 0.5-T MR Angiography: Experimental Study in Rabbits Radiology 2000, 214, 787-794
20. Seki, T.; Fang, J.; Maeda, H. Enhanced Delivery of Macromolecular Antitumor Drugs to Tumors by Nitroglycerin Application Cancer Sci. 2009, 100, 2426-2430
21. Maeda, H. Nitroglycerin Enhances Vascular Blood Flow and Drug Delivery in Hypoxic Tumor Tissues: Analogy between Angina Pectoris and Solid Tumors and Enhancement of the EPR Effect J. Controlled Release 2010, 142, 296-298
22. Maeda, H. Macromolecular Therapeutics in Cancer Treatment: The EPR Effect and Beyond J. Controlled Release 2012, 164, 138-144
23. Suzuki, M.; Hori, K.; Abe, I.; Saito, S.; Sato, H. A New Approach to Cancer Chemotherapy: Selective Enhancement of Tumor Blood Flow with Angiotensin II J. Natl. Cancer Inst. 1981, 67, 663-669
24. El-Sayed, I. H.; Huang, X.; El-Sayed, M. A. Selective Laser Photo-Thermal Therapy of Epithelial Carcinoma Using Anti-EGFR Antibody Conjugated Gold Nanoparticles Cancer Lett. 2006, 239, 129-135
25. Gormley, A. J.; Larson, N.; Sadekar, S.; Robinson, R.; Ray, A.; Ghandehari, H. Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy Nano Today 2012, 7, 158-167
26. Euhus, D. M.; Hudd, C.; LaRegina, M. C.; Johnson, F. E. Tumor Measurement in the Nude Mouse J. Surg. Oncol. 1986, 31, 229-234